Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-02-17FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a generic fixed-dose combination tablet of amlodipine besylate and atorvastatin calcium (AML…
-
FDA approval · 2014-12-01FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lovastatin by Lupin Pharmaceuticals, Inc., resulting in regulatory approval related to the gener…
-
FDA approval · 2014-12-01FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin from Carlsbad Technology, Inc., expanding access to a generic statin.
-
FDA approval · 2014-11-25FDA Approved: SIMVASTATIN — Original Application (XLCare Pharmaceuticals Inc.)
The FDA approved the original application for SIMVASTATIN from XLCare Pharmaceuticals Inc., granting marketing authorization for a generic s…
-
FDA approval · 2014-11-05FDA Approved: SIMVASTATIN — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s supplemental application for simvastatin (generic statin).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-05FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium (generic) from Dr. Reddy's Laboratories Limited. This document confirms the…
-
FDA approval · 2014-11-05FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
FDA approval · 2014-11-05FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for simvastatin, updating the approved generic product.
-
FDA approval · 2014-11-04FDA Approved: SIMVASTATIN — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for simvastatin by Micro Labs Limited under ANDA090383, updating the regulatory status of the approv…
-
FDA approval · 2014-11-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for atorvastatin calcium from Dr. Reddy's Laboratories Limited, confirming approval of a generic ato…
-
FDA approval · 2014-11-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate, confirming approval of a generic fenofibrate product.
-
FDA approval · 2014-11-03FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for pravastatin sodium from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2014-11-03FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for pravastatin sodium, indicating regulatory approval for changes to this …
-
FDA approval · 2014-10-31FDA Approved: FENOFIBRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic fenofibrate under an Original Application.
-
FDA approval · 2014-10-26FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for ATORVASTATIN CALCIUM from Mylan Pharmaceuticals Inc., granting approval of a generic atorvastati…
-
FDA approval · 2014-10-16FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
The FDA approved Cipla USA Inc.'s supplemental application for pravastatin sodium, confirming approval of a generic pravastatin product.
-
FDA approval · 2014-10-09FDA Approved: COLESTIPOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Colestipol hydrochloride by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2014-09-30FDA Approved: ZETIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZETIA (ezetimibe) submitted by Organon LLC. The approval updates the product labeling to reflect…
-
FDA approval · 2014-09-23FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc.
-
FDA approval · 2014-09-23FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium by Mylan Pharmaceuticals, confirming the approval of a generic version of t…
-
FDA approval · 2014-07-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…
-
FDA approval · 2014-07-01FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
The FDA approved a supplemental application for Pravastatin Sodium by Cipla USA Inc.
-
FDA approval · 2014-05-22FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for a fixed-dose combination of amlodipine and atorvastatin (amlodipine besylate and atorvastatin ca…
-
FDA approval · 2014-05-22FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2014-05-20FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc. The action ap…